Outcomes of treatment efficacy | Â |
Aggression* | Â |
Agitation | Â |
Depression | Â |
Apathy | Â |
Anxiety | Â |
Night-time behaviors | Â |
Motor disturbances | Â |
Irritability | Â |
Disinhibition | Â |
Psychosis (delusions and hallucinations) | Â |
Appetite and eating abnormalities | Â |
Caregiver well-being | Â |
Overall quality of life (both patient and caregiver) | Â |
Improvement in function | Â |
Admission to skilled nursing facility | Â |
Outcomes of treatment safety | Â |
Fractures* | Â |
Falls | Â |
Stroke | Â |
Mortality | Â |
Prolonged QTc interval | Â |
Myocardial infarction | Â |
Pneumonia | Â |
Deterioration in cognition | Â |
Hyperprolactinemia | Â |
Weight gain | Â |
Somnolence | Â |
Hypotension | Â |
Edema | Â |
Cytopenia | Â |
Extrapyramidal side effects (e.g., tardive dyskinesia) | Â |
Hospitalization | Â |
Admission to intensive care unit (ICU) | Â |